(Q33364342)
Statements
1 reference
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma (English)
1 reference
Vernon K Sondak
1 reference
Francis P Worden
1 reference
Jeremy M G Taylor
1 reference
Janet S Biermann
1 reference
Kirstin M Leu
1 reference
Rashmi Chugh
1 reference
Cornelius J McGinn
1 reference
Mark M Zalupski
1 reference
Laurence H Baker
1 reference
1 January 2005
1 reference
1 reference
23
1 reference
105-112
1 reference
Identifiers
1 reference
1 reference